Lung cancer working group report.

  title={Lung cancer working group report.},
  author={Nagahiro George Saijo and Masahiro Fukuoka and Sumitra Thongprasert and Yukito Ichinose and Tetsuya Mitsudomi and Tony Shu Kam Mok and Yuichiro Ohe and Keunchil Park and Yi-Long Wu},
  journal={Japanese journal of clinical oncology},
  volume={40 Suppl 1},
Asia needs a guideline for non-small-cell lung cancer because of differences in medical care, medical care insurance, ethnic variation and drug approval lag within Asian countries and compared with Western countries. Due to ethnic differences, drug dosages are often higher in the USA than in Japan. EGFR mutation in non-small-cell lung cancer was detected in 32% of Asians but only 6% of non-Asians, while differences in irinotecan metabolism cause higher frequencies of toxicity (leukopenia… CONTINUE READING